Cross-sectional study of surveillance of suspicious prescriptions, indicators of possible abuse FRESH-PEF73059-en Maryse LAPEYRE-MESTRE Cross-sectional study of surveillance of suspicious prescriptions, indicators of possible abuse OSIAP FRESH-PEF73059-en 73059 FRESH-PEF73059 Maryse LAPEYRE-MESTRE CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) Epidemiology France Portal (PEF) AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE (ANSM) INTERMINISTERIEL null Maryse;LAPEYRE-MESTRE pharmacy abuse indicator prescription surveillance medicines General medicine Psychiatry Addiction medicine Disorders due to use of unknown or unspecified psychoactive substances Behavioral determinants: Addiction Healthcare system determinants: Use of care Behavioral determinants Healthcare system determinants To identify medicines diverted using modified or falsified prescriptions presented at the pharmacy. It also allows for the classification of the most diverted medicines at the regional and national level in relation to the sales data. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) All suspicious prescriptions (coming from CEIP network pharmacies) during the month of the study, registered on a collection form that includes, for each prescription, the demographic characteristics of the requester (sex, age), the name of the medicine(s) involved and the suspicious prescription criteria. The definition of the term "suspicious prescription" corresponds to a prescription that is not the translation of a medical prescription according to the accepted regulatory criteria. It therefore includes: - prescriptions written from a stolen prescription, prescriptions that are photocopied, scanned, prepared on a PC; - prescriptions that have been modified, i.e. valid prescriptions that have subsequently been modified (by addition of a medicine not initially included, or by modification of the dosage or duration of the treatment); - clearly abnormal prescriptions that are not included in the first two situations. Participant-reported health data ATC classification for the registration of medicines Health care consumption and services One-time cross-sectional study Other Through independent healthcare practitioners >= 20000 individuals Interview with the participant (including clinical) Observational Study Observational Study 600-800 Unknown Restricted access Database accessible as part of regulatory activities related to drug abuse and dependence monitoring overseen by ANSM. No direct access to the database. Possibility of collaboration as part of a research project (contact scientific supervisor) Access on specific project only